Andrew Guggenhime - 14 Jan 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
PRESIDENT AND CFO
Signature
Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
14 Jan 2026
Net transactions value
$0
Form type
4
Filing time
16 Jan 2026, 17:09:55 UTC
Previous filing
10 Sep 2025
Next filing
20 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GUGGENHIME ANDREW PRESIDENT AND CFO C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact 16 Jan 2026 0001230724

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Gift $0 -61,850 -50% $0.000000 62,459 14 Jan 2026 Direct F1
transaction PCVX Common Stock Gift $0 +61,850 $0.000000 61,850 14 Jan 2026 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involves the Reporting Person's transfer of shares to ALG 2025 GRAT HOLDINGS LLC, of which Reporting Person is the sole member and manager.
F2 Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the sole annuitant and trustee.